Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Tranylcypromine Reserpine

Theoretically, reserpine might cause hypertension in patients treated with non-selective MAOIs (see Mechanism). On the basis of this the US manufacturer of tranylcypromine contraindicates concurrent use. Conversely, the UK manufacturer of isocarboxazid mentions that it may potentiate the hypotensive effect of reserpine (MAOIs alone can have hypotensive effects). [Pg.1142]

See other pages where Tranylcypromine Reserpine is mentioned: [Pg.191]    [Pg.13]    [Pg.41]    [Pg.138]    [Pg.17]    [Pg.125]    [Pg.302]    [Pg.134]    [Pg.157]    [Pg.174]    [Pg.248]    [Pg.344]    [Pg.393]    [Pg.426]    [Pg.444]    [Pg.497]    [Pg.513]    [Pg.527]    [Pg.610]    [Pg.647]    [Pg.663]    [Pg.702]    [Pg.729]    [Pg.761]    [Pg.816]    [Pg.856]    [Pg.871]    [Pg.881]    [Pg.904]    [Pg.947]    [Pg.964]    [Pg.1023]    [Pg.1069]    [Pg.1110]    [Pg.1220]    [Pg.1242]    [Pg.1298]    [Pg.1331]    [Pg.1365]    [Pg.1476]    [Pg.47]    [Pg.80]    [Pg.134]    [Pg.157]    [Pg.174]    [Pg.209]   
See also in sourсe #XX -- [ Pg.1142 ]



SEARCH



Reserpinization

Tranylcypromine

© 2024 chempedia.info